Prostate Cancer - Results from #19960

The incidence of postoperative ileus in patients who underwent robotic assisted radical prostatectomy - Abstract August 8, 2014

Neoadjuvant before surgery treatments: State of the art in prostate cancer - Abstract August 8, 2014

Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy - Abstract August 8, 2014

Accuracy of transrectal ultrasonography to evaluate pathologic prostate weight: Correlation with various prostate size groups - Abstract August 8, 2014

Effect of caffeine on exercise capacity and function in prostate cancer survivors - Abstract August 8, 2014

Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer - Abstract August 8, 2014

Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging - Abstract August 7, 2014

Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy - Abstract August 7, 2014

Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): An open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial - Abstract August 7, 2014

Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer - Abstract August 7, 2014

The association between insurance status and prostate cancer outcomes: Implications for the Affordable Care Act - Abstract August 7, 2014

"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer - Abstract August 7, 2014

Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up - Abstract August 6, 2014

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network Risk Groups - Abstract August 6, 2014

PSA flare after initiation of abiraterone acetate - Abstract August 6, 2014

The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors - Abstract August 6, 2014

Head to head comparison of two currently used nomograms predicting the risk of side specific extra capsular extension to indicate nerve sparing during radical prostatectomy for treatment of prostate cancer - Abstract August 6, 2014

Urodynamic evaluation before and immediately after robot-assisted radical prostatectomy - Abstract August 6, 2014

Perineural invasion in prostate cancer patients who are potential candidates for active surveillance: Validation study - Abstract August 6, 2014

Prostate size and adverse pathologic features in men undergoing radical prostatectomy - Abstract August 6, 2014

Page 999 of 1436